Deutsche Bank maintains a 'Buy' on Auxilium Pharmaceuticals (Nasdaq: AUXL), price target increased from $34 to $41.

Deutsche analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE